Berlin, April 25, 2024 \u2013 Spring not only brings blooming landscapes to Berlin, but also a breath of fresh air for the Crossinvestics\u00ae innovations group. One of the leading companies in the field of digital health technology is unveiling a comprehensive rebranding of its brand identity, affecting the main brand as well as the subsidiaries Cross4channel\u00ae, Crossinvestics\u00ae management, and Crossinvestics\u00ae innovations & investments. <\/p>\n\n\n\n
The new design manifests itself as a symbol for Innovation and excellence<\/strong> and marks the beginning of a new era for the company in the digital health industry. With the introduction of the modern look, Crossinvestics\u00ae recommits itself to being a leader in the areas of Pharmacovigilance monitoring<\/strong> and Social Media Monitoring<\/strong> The focus on evalii\u00ae, an advanced tool for social media and drug safety monitoring, is particularly highlighted.\u00a0<\/p>\n\n\n\n \u201cOur new look is more than just a visual change,\u201d explains Petra D\u00f6kel, Managing Director of the Crossinvestics\u00ae innovations group. \u201cIt represents our deep commitment to quality, efficiency and trust, and it strengthens our ambition to develop and offer innovative technical solutions for the pharmaceutical industry.\u201d\u00a0<\/p>\n\n\n\n To celebrate the re-orientation, Crossinvestics\u00ae has also completely redesigned its C4C website, which now offers improved user guidance and expanded content to provide customers with a seamless experience. The website acts as a central point of contact for information and services specifically tailored to the needs of the modern pharmaceutical and healthcare industry.\u00a0<\/p>\n\n\n\n The innovations underline Crossinvestics\u00ae\u2019s core competencies in the areas of social media and pharmacovigilance monitoring as well as its know-how for special technical solutions in the healthcare sector. <\/p>\n\n\n\n